Long-term outcomes of systemic therapies for Hurler syndrome: an international multi-center comparison

[1]  J. Eisengart,et al.  Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome , 2017, Molecular genetics and metabolism reports.

[2]  A. Agarwal,et al.  Mucopolysaccharidosis type I, II and VI and response to enzyme replacement therapy: Results from a single-center case series study. , 2017, Intractable & rare diseases research.

[3]  M. Poe,et al.  Early disease progression of Hurler syndrome , 2017, Orphanet Journal of Rare Diseases.

[4]  A. Kemper,et al.  Cognitive outcomes and age of detection of severe mucopolysaccharidosis type 1 , 2017, Genetics in Medicine.

[5]  R. Giugliani,et al.  Immune tolerance induction for laronidase treatment in mucopolysaccharidosis I , 2017, Molecular genetics and metabolism reports.

[6]  P. Orchard,et al.  The Changing Patterns of Graft Failure in MPS1H, Hurler Syndrome: A Review of 30-Years Experience , 2016 .

[7]  S. Richards,et al.  Effect of anti-laronidase antibodies on efficacy and safety of laronidase enzyme replacement therapy for MPS I: A comprehensive meta-analysis of pooled data from multiple studies. , 2016, Molecular genetics and metabolism.

[8]  J. Tolar,et al.  Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres. , 2016, Molecular genetics and metabolism.

[9]  C. Phornphutkul,et al.  Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships , 2015, Orphanet Journal of Rare Diseases.

[10]  K. Lim,et al.  Neurocognition across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment. , 2015, Molecular genetics and metabolism.

[11]  A. Fischer,et al.  Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. , 2015, Blood.

[12]  M. Poe,et al.  Early treatment is associated with improved cognition in Hurler syndrome , 2014, Annals of neurology.

[13]  C. Whitley,et al.  High-dose enzyme replacement therapy in murine Hurler syndrome. , 2014, Molecular genetics and metabolism.

[14]  J. E. Wraith,et al.  Does early use of enzyme replacement therapy alter the natural history of mucopolysaccharidosis I? Experience in three siblings. , 2013, Molecular genetics and metabolism.

[15]  R. Giugliani,et al.  Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice. , 2013, Molecular genetics and metabolism.

[16]  C. Kim,et al.  Enzyme replacement therapy for Mucopolysaccharidosis Type I among patients followed within the MPS Brazil Network , 2013, Genetics and molecular biology.

[17]  J. Tolar,et al.  Enzyme replacement is associated with better cognitive outcomes after transplant in Hurler syndrome. , 2013, The Journal of pediatrics.

[18]  D. Horovitz,et al.  Spinal cord compression in young children with type VI mucopolysaccharidosis. , 2011, Molecular genetics and metabolism.

[19]  W. Roberts,et al.  Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management , 2011, Journal of Inherited Metabolic Disease.

[20]  J. Wagner,et al.  Pre-transplant risk factors affecting outcome in Hurler syndrome , 2010, Bone Marrow Transplantation.

[21]  J. Wagner,et al.  Costs of pediatric allogeneic hematopoietic‐cell transplantation , 2010, Pediatric blood & cancer.

[22]  O. Gabrielli,et al.  Enzyme-Replacement Therapy in a 5-Month-Old Boy With Attenuated Presymptomatic MPS I: 5-Year Follow-up , 2010, Pediatrics.

[23]  B. Bigger,et al.  Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy. , 2009, The Journal of pediatrics.

[24]  J. E. Wraith,et al.  Mucopolysaccharidosis I: Management and Treatment Guidelines , 2009, Pediatrics.

[25]  J. Tolar,et al.  Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation , 2008, Bone Marrow Transplantation.

[26]  T. D. de Koning,et al.  The clinical outcome of Hurler syndrome after stem cell transplantation. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[27]  J. Tolar,et al.  Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome , 2008, Bone Marrow Transplantation.

[28]  A. Kulkarni,et al.  Quality of life in children with hydrocephalus: results from the Hospital for Sick Children, Toronto. , 2007, Journal of neurosurgery.

[29]  J. E. Wraith,et al.  Enzyme Replacement Therapy in Patients Who Have Mucopolysaccharidosis I and Are Younger Than 5 Years: Results of a Multinational Study of Recombinant Human α-l-Iduronidase (Laronidase) , 2007, Pediatrics.

[30]  S. Jacobs,et al.  Outcome after three years of laronidase enzyme replacement therapy in a patient with Hurler syndrome , 2006, Journal of Inherited Metabolic Disease.

[31]  J. Belmont,et al.  Enzyme-replacement therapy in mucopolysaccharidosis I. , 2001, The New England journal of medicine.

[32]  L. Lockman,et al.  Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation , 1995, Journal of Inherited Metabolic Disease.

[33]  A. Barrett,et al.  Reversal of clinical features of hurler's disease and biochemical improvement after treatment by bone marrow transplantation , 1982, Journal of Inherited Metabolic Disease.

[34]  R. Giugliani,et al.  The mucopolysaccharidoses. , 1976, Journal of medical genetics.

[35]  M. Valsecchi,et al.  Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I. , 2015, Blood.

[36]  M. Escolar,et al.  Leukodystrophies and Lysosomal Storage Disorders , 2013 .

[37]  R. Wynn,et al.  Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 patients. , 2009, The Journal of pediatrics.

[38]  E. Paschke,et al.  Enzyme replacement therapy in two patients with an advanced severe (Hurler) phenotype of mucopolysaccharidosis I , 2006, European Journal of Pediatrics.

[39]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .

[40]  J. Kersey,et al.  Bone marrow transplantation for Hurler syndrome: assessment of metabolic correction. , 1986, Birth defects original article series.